ArticleBMC infectious diseases2025
Measuring the disease burden of seasonal influenza in Germany 2015 - 2020 using the incidence-based disability-adjusted life years (DALYs).
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019-2025: Analysis of Nationwide Hospital Data.Infectious diseases and therapy · 2026Article
- SARS-CoV-2-specific immunity after XBB.1.5 vaccination is not significantly altered by subsequent influenza vaccination in dialysis patients.Scientific reports · 2026Observational
- Assessing disability-adjusted life years (DALY) from multiple medication use and multiple illnesses of older adults in rural Thailand.Aging clinical and experimental research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeasonal influenza can lead to severe complications and death, resulting in high disease burden each year. The European Centre for Disease Prevention and Control introduced the Burden of Communicable diseases in Europe (BCoDE) project, quantifying the disease burden of infectious diseases in disability-adjusted life years (DALY). DALYs for influenza exceed those of Tuberculosis, HIV, and Invasive pneumococcal disease. As data on disease burden are limited, this study aims to calculate the seasonal influenza burden for Germany between 2015 and 2020.
methodsThe BCoDE-toolkit developed by the European Centre for Disease Prevention and Control was used, calculating country-specific DALYs. Information on incidence, population data, and underestimation were taken from the Robert Koch-Institute and the Federal Statistical Office of Germany. Outcome trees were created based on information from a rapid review and previous publications. Baseline, lower-bound and upper-bound scenarios were developed to assess the disease burden under varying conditions.
resultsEstimates range from 127,100 DALYs (153 DALYs per 100,000 population) and 1,171,115 DALYs (1,414 DALYs per 100,000 population) depending on the scenario and year examined. The main contributors to the disease burden are sequelae, primarily pneumonia, encephalitis, and myocarditis. The highest burden estimates are observable for infants, children under the age of five and the elderly.
conclusionsUsing a composite health measure like DALY can offer valuable insight into a disease's impact on population health. Our results indicate a high disease burden due to seasonal influenza in Germany, indicating further research into complication rates, underestimation, and intervention programs for vulnerable populations, e.g., vaccination in infants, children under age of five and elderly population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.